Obstructive sleep apnea (OSA) is characterized by. Quality of Life in Patients with Obstructive Sleep Apnea*
|
|
- Cordelia Shaw
- 6 years ago
- Views:
Transcription
1 Quality of Life in Patients with Obstructive Sleep Apnea* Effect of Nasal Continuous Positive Airway Pressure A Prospective Study Carolyn D Ambrosio, MD; Teri Bowman, MD; and Vahid Mohsenin, MD Background: Obstructive sleep apnea (OSA) is a common condition and is associated with excessive daytime sleepiness and neuropsychological dysfunction. There is limited evidence on the effect of OSA on the quality of life and its response to nasal continuous positive airway pressure (ncpap) treatment. Study objective: To determine the effect of ncpap on the quality of life in patients with OSA. Design: Prospective determination of ncpap effect in a case-series analysis. Patients: We studied 29 patients (23 were male and 6 were female) with a mean ( SE) age of years, a body mass index kg/height (m) 2, and a diagnosis of OSA with respiratory disturbance index (RDI; apnea/hypopnea) of 77 9 events/h. Measurements and results: The quality of life was assessed by administering a Medical Outcomes Study Short Form-36 questionnaire before and after 8 weeks of ncpap therapy in polysomnographically documented OSA. All dimensions of the quality of life were significantly impaired when compared with an age- and gender-matched population, expressed as a percentage of normative data: physical functioning, 75%; vitality, 41%; role functioning (physical, 54%; emotional, 61%; social, 66%); general health, 88%; and mental health, 76%. ncpap therapy significantly improved the sleep-disordered breathing and sleep fragmentation. The ncpap level for the group was cm H 2 O. Eight weeks of ncpap therapy improved vitality (75%), social functioning (90%), and mental health (96%). The magnitude of improvement was related to the degree of quality of life impairment prior to treatment, rather than to the severity of disease as measured by the RDI and arousal indices. Conclusions: All aspects of the quality of life, from physical and emotional health to social functioning, are markedly impaired by OSA. ncpap therapy improved those aspects related to vitality, social functioning, and mental health. (CHEST 1999; 115: ) Key words: nasal continuous positive airway pressure; quality of life; sleep apnea Abbreviations: OSA obstructive sleep apnea; ncpap nasal continuous positive airway pressure; SF-36 Medical Outcomes Study Short Form-36; RDI respiratory disturbance index; SE standard error *From the Yale Center for Sleep Disorders, Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT. Manuscript received March 27, 1998; revision accepted July 22, Correspondence to: Dr. Vahid Mohsenin, 333 Cedar St, New Haven, CT 06520; vahid.mohsenin@yale.edu Obstructive sleep apnea (OSA) is characterized by recurrent obstruction of the upper airway, which results in episodic asphyxia, oxygen desaturations, and disruption of the normal sleep pattern. The majority of OSA patients have symptoms related to poor quality sleep, such as excessive daytime sleepiness and tiredness, lack of concentration, memory impairment, and at times psychological disturbances. 1 3 OSA is also associated with cardiovascular and cerebrovascular morbidity and mortality. 4 6 As a result of these symptoms and functional impairments, OSA patients often report having a poor quality of life in social, emotional, and physical domains. 7 9 Treatments for OSA include positional training, weight loss, avoidance of alcohol and sedative drugs, mandibular advancement devices, nasal continuous positive airway pressure (ncpap), and upper airway surgery. The most commonly used and most effective treatment modality has been ncpap ncpap has been shown to decrease the frequency of apneic events and oxygen desaturation during sleep, 10 and to reduce the severity of sleep disturbances and daytime sleepiness. 13,14 In a cross-sectional study by Tousignant et al, 9 CHEST / 115 / 1/ JANUARY,
2 ncpap therapy increased quality adjusted life years. We undertook the present prospective longitudinal study to determine the impact of OSA and ncpap therapy on the overall quality of life. In previous studies, both disease-specific and general assessment tools were used for the estimation of the quality of life measures in OSA. In this study, however, we were interested in evaluating the overall quality of life, rather than symptoms directly associated with the disease. Patients Materials and Methods Twenty-nine patients who were referred to the sleep laboratory for evaluation of sleep-disordered breathing were prospectively enrolled in the study. Those patients with conditions diagnosed as OSA (apnea/hypopnea index 15/h) and given ncpap therapy were included in this study. Patients who had other sleep disorders or received treatment other than ncpap for their OSA were not included in this study. Study Protocol Prior to the onset of ncpap therapy and split-night polysomnography, each patient completed a previously validated health questionnaire, the Medical Outcomes Study Short Form-36 (SF-36), 15 and baseline anthropomorphic measurements were recorded. The optimal ncpap level was determined in the laboratory during the study. Eight weeks later, the SF-36 was readministered, and each patient answered additional questions concerning the number of hours per night and the number of times each week that they received ncpap therapy. Compliance with ncpap was based on self-reports. Quality of Life Assessment The SF-36 questionnaire measures how the patient perceives his/her own functional status, well-being, and overall health. 15,16 The patients were also asked if they had stopped or reduced certain activities because of health or emotional problems, such as depression. They were also asked to assess how much their social activities had been curtailed by their health. The normative data for age- and gender-matched population were used for comparison. 17 Sleep Study Polysomnography was performed between 9:00 pm and 7:00 am as previously described. 18 Briefly described, the sleep state was recorded with two channels of electroencephalogram (C3/A2 or C4/A1, O2/A1 or O1/A2), two channels of electro-oculogram, and one channel of submental electromyogram. Breathing was assessed by monitoring chest wall and abdominal movements using strain gauge pneumographs, and nasal and oral flows were monitored using thermisters. Arterial oxygen saturation was measured using an oximeter (Biox 3700c; Ohmeda; Louisville, CO). Leg movements were monitored with two channels of electromyogram, and an ECG was recorded continuously. All variables were recorded simultaneously and continuously on a 16-channel polygraph (model 78D; Grass Instruments; Quincy, MA). Sleep recordings were scored in 30-s epochs and staged according to standard criteria. 19 Calculated variables included the number of arousals, the respiratory disturbance index (RDI; apnea/hypopnea index), and the number and degree of arterial oxygen desaturations. Apneic variations were classified using the following definitions: apnea was present when there was at least an 80% reduction in airflow for 10 s, obstructive apnea was present when respiratory efforts were present, central apnea was present when respiratory efforts were absent, and mixed apneas occurred when there was a central component followed by an obstructive component. Hypopneas were scored when there was a 50 to 80% decrease in the airflow signal with 4% decrease in arterial oxygen saturation. The optimal ncpap level during the sleep study was the lowest pressure associated with the least number of respiratory events and arousals and the highest sleep efficiency. Statistical Analysis Data are presented as mean SE. Each subject served as his/her own control. The baseline SF-36 parameters were compared with normative data for the same age group using an unpaired Student s t test. 17 The impact of comorbidity on baseline SF-36 parameters was analyzed using analysis of variance. The effects of ncpap therapy on each patient were analyzed using a paired Student s t test. The p value was corrected for multiple comparisons using the Bonferroni adjustment. A linear regression analysis was used to examine the correlation between anthropometric characteristics, indicators of sleep apnea severity, and SF-36 measures. Results Twenty-nine patients (23 were male, and 6 were female) were included in this study. The average age of the patients was years old (range, 23 to 68); the average body mass index was kg/height (m) 2 (range, 21.9 to 54.1). Eight patients had no comorbidities; the others had histories of coronary heart disease, hypertension, COPD, diabetes mellitus, and/or arthritis. All of the patients were medically stable at the time of their initial evaluation and on follow-up. On average, the patients had severe OSA with RDI of 77 9 events/h when sleeping (range, 15 to 200). The apneas were associated with arterial oxygen desaturation, which decreased from % while awake to % during sleep (p 0.001). The severity of sleep apnea and sleep fragmentation for each patient is shown in Figure 1. Sleep was markedly fragmented during the baseline period, with an increased arousal index of 67 7 arousals/h. The patients had significantly decreased health status in all domains of SF-36 role functioning, physical functioning, vitality, mental health, and health perceptions when compared with age-matched control subjects (Fig 2). To determine the effect of the severity of sleep apnea on the quality of life, the indicators of disease severity, the RDI and arousal indices, and the lowest oxygen saturation during sleep were correlated 124 Clinical Investigations
3 Figure 1. Arousal index and RDI before and after ncpap therapy. The side bars denote mean SE. with each domain of the SF-36. There were no significant correlations among any of these measures. Some patients with mild OSA reported significant impairment in their quality of life, although others with more severe OSA perceived a lesser amount of functional decline. The impact of comorbidity on SF-36 domains was examined using analysis of variance for the absence or presence of comorbidity. The presence of comorbidity significantly curtailed role functioning related to work or other daily activities as a result of physical health: with no comorbidity vs with at least one comorbidity (p 0.003). All patients underwent and responded to ncpap treatment, with a reported use time of h/night. The RDI decreased from 77 9to4 6 events/h (p ), and the arousal index decreased from 67 7to13 3 arousals/h (p 0.001) (Fig 1). The arterial oxygen saturation during sleep increased from % to %, and the mean optimal ncpap level was cm H 2 O. After 8 weeks of ncpap treatment, the patients reported a significant improvement in vitality (p ), social functioning (p 0.009), and mental health (p 0.01) when compared to baseline values for each individual. There was no correlation between the severity of sleep apnea, the RDI, the lowest arterial oxygen saturation or frequency of oxygen desaturations, and the degree of improvement in quality of life measures after ncpap treatment. We used multiple regression analysis to identify the factors of age, body mass index, RDI and arousal indices, and the use of ncpap as independent variables that could have predicted the improvement in SF-36 measures. None of these variables had any significant bearing on the changes in SF-36 parameters with ncpap treatment. However, significant correlations were found between quality of life scores on the SF-36 at baseline and prior to ncpap administration and the subsequent change in scores after treatment, except for role physical. In other words, patients with lower scores and more impairments on the SF-36 before treatment demonstrated larger improvements in SF-36 domains after treatment (Fig 3). Discussion Our study demonstrates that the quality of life in patients with OSA is severely impaired and can be improved with ncpap therapy. All domains of the quality of life, from emotional and mental health functioning to vitality and physical health, were impaired by OSA when compared with the agematched normal population. OSA impacted on the quality of life in various ways. Some patients with rather mild OSA reported the same degree of impairment in SF-36 domains, as did those with more severe cases of the disease. The diminished quality of life measures did not correlate with disease severity. Similar to the present study, other investigators have shown no correlation between the severity of sleep apnea, as defined by the number of apnea/hypopnea events per hour, and the health profile indices. 7,8 OSA is commonly associated with neuropsychiatric disturbances that could interfere with the capacity of the patient to fully appreciate the quality of his/her state of health. 1 This could explain the lack of correlation between OSA severity and the self-perceived health status. Our data and the data mentioned above differ from the study of Tousignant et al, 9 which demonstrated a correlation between RDI and pretreatment health state indicating the higher the severity of disease the lower the health status. The reason for this discrepancy may be because this study was conducted retrospectively and, therefore, CHEST / 115 / 1/ JANUARY,
4 Figure 2. SF-36 domains before and after 8 weeks of ncpap treatment. The third column denotes age-matched normative values. The p values are corrected for multiple comparisons using the Bonferroni adjustment. may have been biased because of errors in recall about the pretreatment health state. Furthermore, there were some inconsistencies in the response to treatment in the aforementioned study. The respiratory indices and daytime sleepiness improved with treatment, although there was either worsening or no changes in some of psychological symptoms such as depression. 126 Clinical Investigations
5 Figure 3. The relationship between quality of life domains prior to ncpap treatment and the degree of improvement in these domains after ncpap treatment. An optimal ncpap level was achieved for all patients during the study. The use of ncpap ranged from 3 to 8 h/night for the duration of study. After 8 weeks of ncpap therapy, the SF-36 scores on mental health, social functioning, and vitality improved significantly and were no longer statistically CHEST / 115 / 1/ JANUARY,
6 different from normal age- and gender-matched subject scores. The improvement in these domains was independent of the baseline apnea/hypopnea index or other indicators of OSA severity. The degree of impairment in quality of life domains but not the severity of disease determined the degree of improvement with ncpap. In a study by Engleman et al 20 of 204 ncpap users, there was a significant improvement in daytime sleepiness and a reduction in road traffic incident rate. The use of ncpap correlated positively with symptoms prior to treatment and not with OSA severity. The reported average ( SD) use of ncpap in this study was h/night, which is comparable to our average of h/night. One explanation is that patients with more severe OSA but with less perceived impairment in life domains did not use ncpap regularly and did not report a significant change in their functions. Another reason for the lack of a relationship between OSA severity and the perceived improvement in quality of life could be that patients with severe OSA having cognitive deficit could underestimate the impairment in their own quality of life domains. The patient s symptoms and especially the degree of sleepiness have been shown to be good predictors of acceptance 21,22 or compliance with ncpap therapy. 11,23 Some patients with mild OSA but with more severe impairment in quality of life measures demonstrated significant increases in SF-36 scores after ncpap. This type of response has also been observed by other investigators. 14 However, in the latter study, those with a higher apnea/hypopnea index and increased frequency of microarousal had better compliance and greater improvement in quality of life. Although factors other than sleep apnea, such as obesity and comorbidities, can adversely affect the quality of life, the rapid improvement in functions after ncpap therapy suggests that sleep apnea is the main cause of functional impairment. We used a general instrument rather than a disease-specific instrument to examine the effect of ncpap therapy. Previous studies have already shown improvement in daytime sleepiness and neuropsychiatric manifestations in OSA patients. 3,24 The sleepiness correlated with vitality and general health perception domains of SF-36 in a group of patients with mild to moderate OSA. 25 The fact that some of the SF-36 domains showed significant improvement in the expected direction indicates that this instrument has reasonable sensitivity to show a change after intervention. These types of instruments have the potential for being used in the initial evaluation of OSA patients and perhaps as a predictor of ncpap response. A ncpap study with a longer follow-up period is needed to assess the long-term effect of ncpap treatment on other domains of the quality of life that may have a physical basis. 26 In conclusion, this study demonstrated a marked impairment of the quality of life in patients with even mild OSA, and that 8 weeks of ncpap treatment improves the quality of life domains related to vitality, social functioning, and mental health. References 1 Kales A, Caldwell A, Cadieux R, et al. Severe obstructive sleep apnea-ii: Associated psychological and psychosocial consequences. J Chronic Dis 1985; 38: Greenberg G, Watson R, Deptula D. Neuropsychological dysfunction in sleep apnea. Sleep 1987; 10: Derderian S, Bridenbaugh R, Rajagopal K. Neuropsychologic symptoms in obstructive sleep apnea improve after treatment with nasal continuous positive airway pressure. Chest 1988; 94: Parish M, Shepard J. Cardiovascular effects of sleep disorders. Chest 1990; 97: Stoohs R, Guilleminault C. Cardiovascular changes associated with the obstructive sleep apnea syndrome. J Appl Physiol 1992; 75: Thomas R. The cardiomyopathy of obstructive sleep apnea [letter]. Ann Intern Med 1996; 125:425 7 Gall R, Isaac L, Kryger M. Quality of life in mild obstructive sleep apnea. Sleep 1993; 16:S59 S61 8 Fornas C, Ballester E, Arteta E, et al. Measurement of general health status in obstructive sleep apnea hypopnea patients. Sleep 1995; 18: Tousignant P, Cosio M, Levy R, et al. Quality adjusted life years added by treatment of obstructive sleep apnea. Sleep 1994; 17: Sullivan C, Issa F, Brethon-Jones M, et al. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1981; 1: Waldhorn R, Herrick T, Nguyen M, et al. Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990; 97: Hudgel D. Treatment of obstructive sleep apnea: a review. Chest 1996; 109: Partlett J, Pitson D, Davies R, et al. Daytime vigilance in patients with obstructive sleep apnoea and after CPAP treatment. Thorax 1994; 49: Engleman H, Martin S, Deary I, et al. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997; 52: Ware J, Sherbourne C. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: Ziebland S. The Short Form 36 Health Status Questionnaire: clues from the Oxford region s normative data about its usefulness in measuring health gain in population surveys. J Epidemiol Community Health 1995; 49: Ware J, Snow K, Kosonski K, et al. SF-36 Health survey: manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; Mohsenin V, Valor R. Sleep apnea in patients with hemispheric stroke. Arch Phys Med Rehabil 1995; 76: Rechtschaffen A, Kales A. A manual of standardized techniques and scoring system for sleep stages of human sleep. Los Angeles: Brain Information Service/Brain Research Institute, University of California Los Angeles; Clinical Investigations
7 20 Engleman H, Asgari-Jirhandeh N, McLeod A, et al. Selfreported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996; 109: Rolfe I, Olson L, Saunders N. Long-term acceptance of continuous positive airway pressure in obstructive sleep apnea. Am Rev Respir Dis 1991; 144: Rauscher H, Popp W, Wanke T, et al. Acceptance of CPAP therapy for sleep apnea. Chest 1991; 100: Krieger J, Kurtz D, Petiau C, et al. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep 1996; 19:S136 S Rajagopal K, Bennett L, Dillard T, et al. Overnight nasal CPAP improves hypersomnolence in sleep apnea. Chest 1986; 90: Briones B, Adams N, Strauss M, et al. Relationship between sleepiness and general health status. Sleep 1996; 19: Wright J, Johns R, Watt I, et al. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airway pressure: a systematic review of the research evidence. BMJ 1997; 314: CHEST / 115 / 1/ JANUARY,
Sleep Apnea: Vascular and Metabolic Complications
Sleep Apnea: Vascular and Metabolic Complications Vahid Mohsenin, M.D. Professor of Medicine Yale University School of Medicine Director, Yale Center for Sleep Medicine Definitions Apnea: Cessation of
More informationRESEARCH PACKET DENTAL SLEEP MEDICINE
RESEARCH PACKET DENTAL SLEEP MEDICINE American Academy of Dental Sleep Medicine Dental Sleep Medicine Research Packet Page 1 Table of Contents Research: Oral Appliance Therapy vs. Continuous Positive Airway
More information(To be filled by the treating physician)
CERTIFICATE OF MEDICAL NECESSITY TO BE ISSUED TO CGHS BENEFICIAREIS BEING PRESCRIBED BILEVEL CONTINUOUS POSITIVE AIRWAY PRESSURE (BI-LEVEL CPAP) / BI-LEVEL VENTILATORY SUPPORT SYSTEM Certification Type
More informationPrediction of sleep-disordered breathing by unattended overnight oximetry
J. Sleep Res. (1999) 8, 51 55 Prediction of sleep-disordered breathing by unattended overnight oximetry L. G. OLSON, A. AMBROGETTI ands. G. GYULAY Discipline of Medicine, University of Newcastle and Sleep
More informationTemperature controlled radiofrequency ablation for OSA
Temperature controlled radiofrequency ablation for OSA Ridhwan Y. Baba, M.B.B.S. *1, V.V.S. Ramesh Metta, M.B.B.S. 1, Arjun Mohan, M.B.B.S. 2, M. Jeffery Mador, M.D. 2 1 Department of Internal Medicine,
More informationAcceptance and long-term compliance with ncpap in patients with obstructive sleep apnoea syndrome
Eur Respir J, 1996, 9, 939 944 DOI: 10.1183/09031936.96.09050939 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 Acceptance and long-term
More informationEffect of two types of mandibular advancement splints on snoring and obstructive sleep apnoea
European Journal of Orthodontics 20 (1998) 293 297 1998 European Orthodontic Society Effect of two types of mandibular advancement splints on snoring and obstructive sleep apnoea J. Lamont*, D. R. Baldwin**,
More informationT he daytime consequences of the obstructive
68 REVIEW SERIES Sleep? 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome H M Engleman, N J Douglas... Sleepiness, cognitive performance, and quality
More informationMedicare CPAP/BIPAP Coverage Criteria
Medicare CPAP/BIPAP Coverage Criteria For any item to be covered by Medicare, it must 1) be eligible for a defined Medicare benefit category, 2) be reasonable and necessary for the diagnosis or treatment
More informationInfluence of correction of flow limitation on continuous positive airway pressure efficiency in sleep apnoea/hypopnoea syndrome
Eur Respir J 1998; 11: 1121 1127 DOI: 1.1183/931936.98.1151121 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1998 European Respiratory Journal ISSN 93-1936 Influence of correction of flow
More informationNasal pressure recording in the diagnosis of sleep apnoea hypopnoea syndrome
56 Unité de Recherche, Centre de Pneumologie de l Hôpital Laval, Université Laval, Québec, Canada F Sériès I Marc Correspondence to: Dr F Sériès, Centre de Pneumologie, 2725 Chemin Sainte Foy, Sainte Foy
More informationThe most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome
The most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome Natsios Georgios University Hospital of Larissa, Greece Definitions Obstructive Sleep Apnea (OSA)
More informationObstructive sleep apnea (OSA) is the periodic reduction
Obstructive Sleep Apnea and Oxygen Therapy: A Systematic Review of the Literature and Meta-Analysis 1 Department of Anesthesiology, Toronto Western Hospital, University Health Network, University of Toronto,
More informationThe STOP-Bang Equivalent Model and Prediction of Severity
DOI:.5664/JCSM.36 The STOP-Bang Equivalent Model and Prediction of Severity of Obstructive Sleep Apnea: Relation to Polysomnographic Measurements of the Apnea/Hypopnea Index Robert J. Farney, M.D. ; Brandon
More informationPolysomnography (PSG) (Sleep Studies), Sleep Center
Policy Number: 1036 Policy History Approve Date: 07/09/2015 Effective Date: 07/09/2015 Preauthorization All Plans Benefit plans vary in coverage and some plans may not provide coverage for certain service(s)
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Obstructive sleep apnoea How to identify? Walter McNicholas MD Newman Professor in Medicine, St. Vincent s University Hospital, University College Dublin, Ireland. Potential
More informationObstructive sleep apnoea How to identify?
Obstructive sleep apnoea How to identify? Walter McNicholas MD Newman Professor in Medicine, St. Vincent s University Hospital, University College Dublin, Ireland. Potential conflict of interest None Obstructive
More informationComparison of two in-laboratory titration methods to determine evective pressure levels in patients with obstructive sleep apnoea
Thorax 2000;55:741 745 741 Centre de Recherche, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l Université Laval, Sainte-Foy, Québec G1V 4G5, Canada M P Bureau F Sériès Correspondence
More informationSleepiness, Fatigue, Tiredness, and Lack of Energy in Obstructive Sleep Apnea*
Sleepiness, Fatigue, Tiredness, and Lack of Energy in Obstructive Sleep Apnea* Ronald D. Chervin, MD, MS Study objectives: Sleepiness is a key symptom in obstructive sleep apnea syndrome (OSAS) and can
More informationSleep and the Heart Reversing the Effects of Sleep Apnea to Better Manage Heart Disease
1 Sleep and the Heart Reversing the Effects of Sleep Apnea to Better Manage Heart Disease Rami Khayat, MD Professor of Internal Medicine Director, OSU Sleep Heart Program Medical Director, Department of
More informationFlorence Morisson, MSc, DMD; Anne Décary, PhD; Dominique Petit, PhD; Gilles Lavigne, MSc, DMD; Jacques Malo, MD; and Jacques Montplaisir, MD, PhD
Daytime Sleepiness and EEG Spectral Analysis in Apneic Patients Before and After Treatment With Continuous Positive Airway Pressure* Florence Morisson, MSc, DMD; Anne Décary, PhD; Dominique Petit, PhD;
More informationCircadian Variations Influential in Circulatory & Vascular Phenomena
SLEEP & STROKE 1 Circadian Variations Influential in Circulatory & Vascular Phenomena Endocrine secretions Thermo regulations Renal Functions Respiratory control Heart Rhythm Hematologic parameters Immune
More informationStephanie Mazza, Jean-Louis Pepin, Chrystele Deschaux, Bernadette Naegele, and Patrick Levy
Analysis of Error Profiles Occurring during the OSLER Test A Sensitive Mean of Detecting Fluctuations in Vigilance in Patients with Obstructive Sleep Apnea Syndrome Stephanie Mazza, Jean-Louis Pepin, Chrystele
More informationIn 1994, the American Sleep Disorders Association
Unreliability of Automatic Scoring of MESAM 4 in Assessing Patients With Complicated Obstructive Sleep Apnea Syndrome* Fabio Cirignotta, MD; Susanna Mondini, MD; Roberto Gerardi, MD Barbara Mostacci, MD;
More informationCPAP titration by an auto-cpap device based on snoring detection: a clinical trial and economic considerations
Eur Respir J 199; : 759 7 DOI:.113/09031936.9.0759 Printed in UK - all rights reserved Copyright ERS Journals Ltd 199 European Respiratory Journal ISSN 0903-1936 CPAP titration by an auto-cpap device based
More informationHealth-related quality of life in obstructive sleep apnoea
Eur Respir J 2002; 19: 499 503 DOI: 10.1183/09031936.02.00216902 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2002 European Respiratory Journal ISSN 0903-1936 Health-related quality of
More informationHealthy Sleep. Frederick Tolle, M.D., dabsm Community Health Network
Healthy Sleep Frederick Tolle, M.D., dabsm Community Health Network Adults should sleep 7 or more hours per night on a regular basis to promote optimal health. Getting less than 7 hours of sleep on average
More informationDiagnostic Accuracy of the Multivariable Apnea Prediction (MAP) Index as a Screening Tool for Obstructive Sleep Apnea
Original Article Diagnostic Accuracy of the Multivariable Apnea Prediction (MAP) Index as a Screening Tool for Obstructive Sleep Apnea Ahmad Khajeh-Mehrizi 1,2 and Omid Aminian 1 1. Occupational Sleep
More informationAbout VirtuOx. Was marketed exclusively by Phillips Healthcare division, Respironics for 3 years
About VirtuOx VirtuOx, Inc. assists physicians and Durable Medical Equipment (DME)( companies diagnose respiratory diseases and qualify patients for home respiratory equipment under the guidelines of CMS
More informationKey words: adenotonsillectomy; arousal; rapid eye movement sleep; sleep apnea
Sleep Characteristics Following Adenotonsillectomy in Children With Obstructive Sleep Apnea Syndrome* Asher Tal, MD; Amir Bar, MD; Alberto Leiberman, MD; and Ariel Tarasiuk, PhD Objective: To compare the
More informationEFFICACY OF MODAFINIL IN 10 TAIWANESE PATIENTS WITH NARCOLEPSY: FINDINGS USING THE MULTIPLE SLEEP LATENCY TEST AND EPWORTH SLEEPINESS SCALE
EFFICACY OF MODAFINIL IN 10 TAIWANESE PATIENTS WITH NARCOLEPSY: FINDINGS USING THE MULTIPLE SLEEP LATENCY TEST AND EPWORTH SLEEPINESS SCALE Shih-Bin Yeh 1 and Carlos Hugh Schenck 2,3 1 Department of Neurology
More informationCoding for Sleep Disorders Jennifer Rose V. Molano, MD
Practice Coding for Sleep Disorders Jennifer Rose V. Molano, MD Accurate coding is an important function of neurologic practice. This section of is part of an ongoing series that presents helpful coding
More information* Cedars Sinai Medical Center, Los Angeles, California, U.S.A.
Sleep. 18(2):115-126 1995 American Sleep Disorders Association and Sleep Research Society Home Monitoring-Actimetry Assessment of Accuracy and Analysis Time of a Novel Device to Monitor Sleep and Breathing
More informationChristopher D. Turnbull 1,2, Daniel J. Bratton 3, Sonya E. Craig 1, Malcolm Kohler 3, John R. Stradling 1,2. Original Article
Original Article In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP Christopher D. Turnbull
More informationMario Kinsella MD FAASM 10/5/2016
Mario Kinsella MD FAASM 10/5/2016 Repetitive episodes of apnea or reduced airflow Due to upper airway obstruction during sleep Patients often obese Often have hypertension or DM 1 Obstructive apneas, hypopneas,
More informationNational Sleep Disorders Research Plan
Research Plan Home Foreword Preface Introduction Executive Summary Contents Contact Us National Sleep Disorders Research Plan Return to Table of Contents SECTION 5 - SLEEP DISORDERS SLEEP-DISORDERED BREATHING
More informationEfremidis George, Varela Katerina, Spyropoulou Maria, Beroukas Lambros, Nikoloutsou Konstantina, and Georgopoulos Dimitrios
Sleep Disorders Volume 2012, Article ID 324635, 5 pages doi:10.1155/2012/324635 Clinical Study Clinical Features and Polysomnographic Findings in Greek Male Patients with Obstructive Sleep Apnea Syndrome:
More informationSleep Diordered Breathing (Part 1)
Sleep Diordered Breathing (Part 1) History (for more topics & presentations, visit ) Obstructive sleep apnea - first described by Charles Dickens in 1836 in Papers of the Pickwick Club, Dickens depicted
More informationQUESTIONS FOR DELIBERATION
New England Comparative Effectiveness Public Advisory Council Public Meeting Hartford, Connecticut Diagnosis and Treatment of Obstructive Sleep Apnea in Adults December 6, 2012 UPDATED: November 28, 2012
More informationDiabetes & Obstructive Sleep Apnoea risk. Jaynie Pateraki MSc RGN
Diabetes & Obstructive Sleep Apnoea risk Jaynie Pateraki MSc RGN Non-REM - REM - Both - Unrelated - Common disorders of Sleep Sleep Walking Night terrors Periodic leg movements Sleep automatism Nightmares
More informationIndex SLEEP MEDICINE CLINICS. Note: Page numbers of article titles are in boldface type.
549 SLEEP MEDICINE CLINICS Sleep Med Clin 1 (2007) 549 553 Note: Page numbers of article titles are in boldface type. A Abdominal motion, in assessment of sleep-related breathing disorders, 452 454 Adherence,
More informationSleep apnea syndrome (SAS) is a chronic illness
Slow-Wave Activity in Sleep Apnea Patients Before and After Continuous Positive Airway Pressure Treatment* Contribution to Daytime Sleepiness Raphaël Heinzer, MD; Hélène Gaudreau, MSc; Anne Décary, PhD;
More informationOnline Supplement. Relationship Between OSA Clinical Phenotypes and CPAP Treatment Outcomes
Relationship Between OSA Clinical Phenotypes and CPAP Treatment Outcomes Frédéric Gagnadoux, MD, PhD; Marc Le Vaillant, PhD; Audrey Paris, MD, PhD; Thierry Pigeanne, MD; Laurence Leclair-Visonneau, MD;
More informationTherapy with ncpap: incomplete elimination of Sleep Related Breathing Disorder
Eur Respir J 2000; 16: 921±927 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2000 European Respiratory Journal ISSN 0903-1936 Therapy with ncpap: incomplete elimination of Sleep Related
More informationThe Effect of a Mandibular Advancement Device on Apneas and Sleep in Patients With Obstructive Sleep Apnea*
The Effect of a Mandibular Advancement Device on Apneas and Sleep in Patients With Obstructive Sleep Apnea* Marie Marklund, DDS; Karl A. Franklin, MD, PhD, FCCP; Carin Sahlin, RTA; and Rune Lundgren, MD,
More informationPharyngeal Critical Pressure in Patients with Obstructive Sleep Apnea Syndrome Clinical Implications
Pharyngeal Critical Pressure in Patients with Obstructive Sleep Apnea Syndrome Clinical Implications EMILIA SFORZA, CHRISTOPHE PETIAU, THOMAS WEISS, ANNE THIBAULT, and JEAN KRIEGER Sleep Disorders Unit,
More informationIn-Patient Sleep Testing/Management Boaz Markewitz, MD
In-Patient Sleep Testing/Management Boaz Markewitz, MD Objectives: Discuss inpatient sleep programs and if they provide a benefit to patients and sleep centers Identify things needed to be considered when
More informationInternet Journal of Medical Update
Internet Journal of Medical Update 2009 July;4(2):24-28 Internet Journal of Medical Update Journal home page: http://www.akspublication.com/ijmu Original Work EEG arousal prediction via hypoxemia indicator
More informationShyamala Pradeepan. Staff Specialist- Department of Respiratory and Sleep Medicine. John Hunter Hospital. Conjoint lecturer University of New Castle.
Shyamala Pradeepan Staff Specialist- Department of Respiratory and Sleep Medicine. John Hunter Hospital. Conjoint lecturer University of New Castle. What is sleep apnoea?? Repetitive upper airway narrowing
More informationEmerging Nursing Roles in Collaborative Management of Sleep Disordered Breathing and Obstructive Sleep Apnoea
Emerging Nursing Roles in Collaborative Management of Sleep Disordered Breathing and Obstructive Sleep Apnoea Sigma Theta Tau International 28th International Nursing Research Congress 27-31 July 2017
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process
Quality ID #277: Sleep Apnea: Severity Assessment at Initial Diagnosis National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic Conditions 2019 COLLECTION
More informationThe Familial Occurrence of Obstructive Sleep Apnoea Syndrome (OSAS)
Global Journal of Respiratory Care, 2014, 1, 17-21 17 The Familial Occurrence of Obstructive Sleep Apnoea Syndrome (OSAS) Piotr Bielicki, Tadeusz Przybylowski, Ryszarda Chazan * Department of Internal
More informationSleep and the Heart. Physiologic Changes in Cardiovascular Parameters during Sleep
Sleep and the Heart Rami N. Khayat, MD Professor of Internal Medicine Medical Director, Department of Respiratory Therapy Division of Pulmonary, Critical Care and Sleep Medicine The Ohio State University
More informationSleep and the Heart. Rami N. Khayat, MD
Sleep and the Heart Rami N. Khayat, MD Professor of Internal Medicine Medical Director, Department of Respiratory Therapy Division of Pulmonary, Critical Care and Sleep Medicine The Ohio State University
More informationPhilip L. Smith, MD; Christopher P. O Donnell, PhD; Lawrence Allan, BS; and Alan R. Schwartz, MD
A Physiologic Comparison of Nasal and Oral Positive Airway Pressure* Philip L. Smith, MD; Christopher P. O Donnell, PhD; Lawrence Allan, BS; and Alan R. Schwartz, MD Study objectives: The effectiveness
More informationControlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy
Eur Respir J 2001; 18: 996 1002 Copyright #ERS Journals Ltd 2001 DOI: 10.1183/09031936.01.00209301 European Respiratory Journal Printed in UK all rights reserved ISSN 0903-1936 Controlled, prospective
More informationDuring the therapeutic titration of nasal continuous
Cardiogenic Oscillations on the Airflow Signal During Continuous Positive Airway Pressure as a Marker of Central Apnea* Indu Ayappa, PhD; Robert G. Norman, MS, RRT; and David M. Rapoport, MD, FCCP Therapeutic
More informationAssessment of a wrist-worn device in the detection of obstructive sleep apnea
Sleep Medicine 4 (2003) 435 442 Original article Assessment of a wrist-worn device in the detection of obstructive sleep apnea Najib T. Ayas a,b,c, Stephen Pittman a,c, Mary MacDonald c, David P. White
More informationPEDIATRIC OBSTRUCTIVE SLEEP APNEA (OSA)
PEDIATRIC OBSTRUCTIVE SLEEP APNEA (OSA) DEFINITION OSA Inspiratory airflow is either partly (hypopnea) or completely (apnea) occluded during sleep. The combination of sleep-disordered breathing with daytime
More informationManagement of OSA in the Acute Care Environment. Robert S. Campbell, RRT FAARC HRC, Philips Healthcare May, 2018
Management of OSA in the Acute Care Environment Robert S. Campbell, RRT FAARC HRC, Philips Healthcare May, 2018 1 Learning Objectives Upon completion, the participant should be able to: Understand pathology
More informationΣύνδρομο σπνικής άπνοιας. Ποιός o ρόλος ηοσ ζηη γένεζη και ανηιμεηώπιζη ηων αρρσθμιών;
Σύνδρομο σπνικής άπνοιας. Ποιός o ρόλος ηοσ ζηη γένεζη και ανηιμεηώπιζη ηων αρρσθμιών; E.N. Σημανηηράκης MD, FESC Επίκ. Καθηγηηής Καρδιολογίας Πανεπιζηημιακό Νοζοκομείο Ηρακλείοσ Epidemiology 4% 2% 24%
More informationHeather M Engleman, Sascha E Martin, Ruth N Kingshott, Thomas W Mackay, Ian J Deary, Neil J Douglas
Thorax 1998;53:341 345 341 Rapid communication Respiratory Medicine Unit H M Engleman S E Martin R N Kingshott T W Mackay N J Douglas Department of Psychology I J Deary University of Edinburgh, UK Correspondence
More informationAHA Sleep Apnea and Cardiovascular Disease. Slide Set
AHA 2008 Sleep Apnea and Cardiovascular Disease Slide Set Based on the AHA 2008 Scientific Statement Sleep Apnea and Cardiovascular Disease Virend K. Somers, MD, DPhil, FAHA, FACC Mayo Clinic and Mayo
More informationThe role of mean inspiratory effort on daytime sleepiness
Eur Respir J 2003; 21: 688 694 DOI: 10.1183/09031936.03.00298903 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2003 European Respiratory Journal ISSN 0903-1936 The role of mean inspiratory
More informationSplit-Night Protocol*
Titration for Sleep Apnea Using a Split-Night Protocol* Yoshihiro Yamashiro, MD, and Meir H. Kryger, MD, FCCP We studied 107 patients with sleep-disordered breathing to confirm the effectiveness of continuous
More informationPediatric Sleep-Disordered Breathing
Pediatric Sleep-Disordered Breathing OSA in infants and young children is generally characterized by partial, persistent obstruction of the upper airway Continuum Benign primary snoring Upper-airway resistance
More informationOBSTRUCTIVE SLEEP APNEA and WORK Treatment Update
OBSTRUCTIVE SLEEP APNEA and WORK Treatment Update David Claman, MD Professor of Medicine Director, UCSF Sleep Disorders Center 415-885-7886 Disclosures: None Chronic Sleep Deprivation (0 v 4 v 6 v 8 hrs)
More informationHHS Public Access Author manuscript Respirology. Author manuscript; available in PMC 2017 October 01.
Connecting insomnia, sleep apnoea and depression Michael A. Grandner, PhD, MTR 1 and Atul Malhotra, MD 2 1 Sleep and Health Research Program, Department of Psychiatry, University of Arizona College of
More informationPatients with upper airway resistance syndrome
Two-Point Palatal Discrimination in Patients With Upper Airway Resistance Syndrome, Obstructive Sleep Apnea Syndrome, and Normal Control Subjects* Christian Guilleminault, MD, BiolD; Kasey Li, MD, DDS;
More informationInspiratory flow-volume curve in snoring patients with and without obstructive sleep apnea
Brazilian Journal of Medical and Biological Research (1999) 32: 407-411 Flow-volume curve and obstructive sleep apnea ISSN 0100-879X 407 Inspiratory flow-volume curve in snoring patients with and without
More informationGOALS. Obstructive Sleep Apnea and Cardiovascular Disease (OVERVIEW) FINANCIAL DISCLOSURE 2/1/2017
Obstructive Sleep Apnea and Cardiovascular Disease (OVERVIEW) 19th Annual Topics in Cardiovascular Care Steven Khov, DO, FAAP Pulmonary Associates of Lancaster, Ltd February 3, 2017 skhov2@lghealth.org
More informationJosé Haba-Rubio, MD; Jean-Paul Janssens, MD; Thierry Rochat, MD, PhD; and Emilia Sforza, MD, PhD
Rapid Eye Movement-Related Disordered Breathing* Clinical and Polysomnographic Features José Haba-Rubio, MD; Jean-Paul Janssens, MD; Thierry Rochat, MD, PhD; and Emilia Sforza, MD, PhD Objective: The existence
More informationSleep Apnea and Body Position during Sleep
Sleep 11(1):9-99, Raven Press, Ltd" New York 1988 Association of Professional Sleep Societies Sleep Apnea and Body Position during Sleep C. F. George, T. W. Millar, and M. H. Kryger Department / Respiratory
More informationORIGINAL ARTICLE. Validation of the Snore Outcomes Survey for Patients With Sleep-Disordered Breathing
Validation of the Snore Outcomes Survey for Patients With Sleep-Disordered Breathing Richard E. Gliklich, MD; Pa-Chun Wang, MD, MSc ORIGINAL ARTICLE Objective: To develop and validate a self-reported outcomes
More informationPositive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea
Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea Policy Number: Original Effective Date: MM.01.009 11/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO
More informationNASAL CONTINUOUS POSITIVE AIRWAY PRESSURE FOR OBSTRUCTIVE SLEEP APNEA IN CHILDREN. Dr. Nguyễn Quỳnh Anh Department of Respiration 1
1 NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE FOR OBSTRUCTIVE SLEEP APNEA IN CHILDREN Dr. Nguyễn Quỳnh Anh Department of Respiration 1 CONTENTS 2 1. Preface 2. Definition 3. Etiology 4. Symptoms 5. Complications
More informationSLEEP DISORDERED BREATHING The Clinical Conditions
SLEEP DISORDERED BREATHING The Clinical Conditions Robert G. Hooper, M.D. In the previous portion of this paper, the definitions of the respiratory events that are the hallmarks of problems with breathing
More informationMore than 20 years ago, before obstructive sleep. Gender Differences in Sleep Apnea* The Role of Neck Circumference
Gender Differences in Sleep Apnea* The Role of Neck Circumference David R. Dancey, MD; Patrick J. Hanly, MD; Christine Soong, BSc; Bert Lee, BSc; John Shepard, Jr., MD, FCCP; and Victor Hoffstein, PhD,
More informationDoes arousal frequency predict daytime function?
Eur Respir J 1998; 12: 1264 1270 DOI: 10.1183/09031936.98.12061264 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1998 European Respiratory Journal ISSN 0903-1936 Does arousal frequency
More informationA 74-year-old man with severe ischemic cardiomyopathy and atrial fibrillation
1 A 74-year-old man with severe ischemic cardiomyopathy and atrial fibrillation The following 3 minute polysomnogram (PSG) tracing was recorded in a 74-year-old man with severe ischemic cardiomyopathy
More informationPressure-Relief Continuous Positive Airway Pressure vs Constant Continuous Positive Airway Pressure* A Comparison of Efficacy and Compliance
Original Research SLEEP MEDICINE Pressure-Relief Continuous Positive Airway Pressure vs Constant Continuous Positive Airway Pressure* A Comparison of Efficacy and Compliance Georg Nilius, MD; Andreas Happel;
More informationMandibular Advancement Device vs CPAP in the Treatment of Obstructive Sleep Apnea: Are they Equally Effective in Short Term Health Outcomes?
NoSnores Mandibular Advancement Device (mouthguard) for Snoring & Sleep Apnea CLINICAL REFERENCES J Clin Sleep Med. 2013 Sep;9(9):971-2. doi: 10.5664/jcsm.3008. Mandibular Advancement Device vs CPAP in
More informationPatients with COPD run a risk of developing. Underestimation of Nocturnal Hypoxemia Due to Monitoring Conditions in Patients With COPD*
Underestimation of Nocturnal Hypoxemia Due to Monitoring Conditions in Patients With COPD* Folkert Brijker, MD; Frank J. J. van den Elshout, MD, PhD; Yvonne F. Heijdra, MD, PhD; and Hans Th. M. Folgering,
More informationAccuracy of Oximetry for Detection of Respiratory Disturbances in Sleep Apnea Syndrome*
Accuracy of Oximetry for Detection of Respiratory Disturbances in Sleep Apnea Syndrome* Patrick Levy, MD, PhD; Jean Louis PCpin, MD; C. Deschaux-Blanc, MSc; B. Paramelle, MD; and Christian Bramhilla, MD
More informationBTS sleep Course. Module 10 Therapies I: Mechanical Intervention Devices (Prepared by Debby Nicoll and Debbie Smith)
BTS sleep Course Module 10 Therapies I: Mechanical Intervention Devices (Prepared by Debby Nicoll and Debbie Smith) S1: Overview of OSA Definition History Prevalence Pathophysiology Causes Consequences
More informationO bstructive sleep apnoea-hypopnoea (OSAH) is a highly
422 SLEEP-DISORDERED BREATHING Predictive value of automated oxygen saturation analysis for the diagnosis and treatment of obstructive sleep apnoea in a home-based setting V Jobin, P Mayer, F Bellemare...
More informationThe Effect of Altitude Descent on Obstructive Sleep Apnea*
CHEST The Effect of Altitude Descent on Obstructive Sleep Apnea* David Patz, MD, FCCP; Mark Spoon, RPSGT; Richard Corbin, RPSGT; Michael Patz, BA; Louise Dover, RPSGT; Bruce Swihart, MA; and David White,
More informationSplit-Night Studies for the Diagnosis and Treatment of Sleep-Disordered Breathing
Sleep, 19(10):S255-S259 1996 American Sleep Disorders Association and Sleep Research Society Split-Night Studies for the Diagnosis and Treatment of Sleep-Disordered Breathing ". Patrick J. Strollo Jr.,
More informationOxygen treatment of sleep hypoxaemia in Duchenne
Thorax 1989;44:997-1001 Oxygen treatment of sleep hypoxaemia in Duchenne muscular dystrophy P E M SMITH, R H T EDWARDS, P M A CALVERLEY From the Muscle Research Centre, University Department ofmedicine
More informationScreening for Sleep Apnea-Hypopnea
Cost-effectiveness Analysis of Nocturnal Oximetry as a Method of Screening for Sleep Apnea-Hypopnea Syndrome* Lawrence J. Epstein, MD, FCCP;f and Gina R. Dorlac, MDt Study objective: Determine the utility
More informationPolicy Specific Section: October 1, 2010 January 21, 2013
Medical Policy Bi-level Positive Airway Pressure (BPAP/NPPV) Type: Medical Necessity/Not Medical Necessity Policy Specific Section: Durable Medical Equipment Original Policy Date: Effective Date: October
More informationMandibular Advancement Device : Long-term Effects on Apnea and Sleep
Mandibular Advancement Device With Obstructive Sleep Apnea * in Patients : Long-term Effects on Apnea and Sleep Marie Marklund, Carin Sahlin, Hans Stenlund, Maurits Persson and Karl A. Franklin Chest 2001;120;162-169
More informationNew Government O2 Criteria and Expert Panel. Jennifer Despain, RPSGT, RST, AS
New Government O2 Criteria and Expert Panel Jennifer Despain, RPSGT, RST, AS Lead Sleep Technologist, Central Utah Clinic Sleep Disorders Center; Provo, Utah Objectives: Review new government O2 criteria
More informationObstructive Sleep Apnea and COPD overlap syndrome. Financial Disclosures. Outline 11/1/2016
Obstructive Sleep Apnea and COPD overlap syndrome Chitra Lal, MD, FCCP, FAASM Associate Professor of Medicine, Pulmonary, Critical Care, and Sleep, Medical University of South Carolina Financial Disclosures
More informationPredictive value of clinical features for the obstructive sleep apnoea syndrome
Eur Respir J, 1996, 9, 117 124 DOI: 10.1183/09031936.96.09010117 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 Predictive value of clinical
More informationRemoval of the CPAP Therapy Device During Sleep and Its Association With Body Position Changes and Oxygen Desaturations
Removal of the CPAP Therapy Device During Sleep and Its Association With Body Position Changes and Oxygen Desaturations Yasuhiro Yamaguchi MD PhD, Shinichiro Hibi MD PhD, Masaki Ishii MD PhD, Yoko Hanaoka
More informationSedative Use During Continuous Positive Airway Pressure Titration Improves Subsequent Compliance. A Randomized, Double-Blind, Placebo-Controlled Trial
CHEST Sedative Use During Continuous Positive Airway Pressure Titration Improves Subsequent Compliance A Randomized, Double-Blind, Placebo-Controlled Trial Christopher J. Lettieri, MD, FCCP; Jacob F. Collen,
More informationOpioids Cause Central and Complex Sleep Apnea in Humans and Reversal With Discontinuation: A Plea for Detoxification
pii: jc-16-00020 http://dx.doi.org/10.5664/jcsm.6628 CASE REPORTS Opioids Cause Central and Complex Sleep Apnea in Humans and Reversal With Discontinuation: A Plea for Detoxification Shahrokh Javaheri,
More informationGeneral Outline. General Outline. Pathogenesis of Metabolic Dysfunction in Sleep Apnea: The Role of Sleep Fragmentation and Intermittent Hypoxemia
Pathogenesis of Metabolic in Sleep Apnea: The Role of Sleep Fragmentation and Intermittent Hypoxemia Naresh M. Punjabi, MD, PhD Associate Professor of Medicine and Epidemiology Johns Hopkins University,
More informationAutomated analysis of digital oximetry in the diagnosis of obstructive sleep apnoea
302 Division of Respiratory Medicine, Department of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1 J-C Vázquez W H Tsai W W Flemons A Masuda R Brant E Hajduk W A Whitelaw J E Remmers
More information